Alamar Biosciences, Inc.

NASDAQ:ALMR

Biotechnology

Healthcare
$30.51 +5.50%

+$1.11 today

Market cap
$2.12B
Beta
0.00
P/E (TTM)
-47.5
EPS (TTM)
-$0.45
52W Low $18.85High $27.20

Volume 0.53M

Average 0.38M

ALMR Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Alamar Biosciences, Inc.NASDAQ: ALMR

Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026

Cost of revenue of $11.71M in Q2 FY2026

Q2 FY2026 cost of revenue was $11.71M.

Context

  • Cost of revenue amounted to 43.8% of revenue in FY2025.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$11.71M+1.1% QoQ
Last fiscal yearDec 2025
$32.51M— YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
32.51M USD
Year-over-year change
—

Cost of Revenue vs competitors

How ALMR compares with its peers on the latest reported figures

  • ALMR's FY2025 cost of revenue of $32.51M is the 6th highest of the 9 companies compared; the peer median is $72.64M.
  • Cost of revenue amounts to 43.8% of revenue for ALMR, versus a peer median of 51.7%.
ALMR Competitors Peer median
Cost of Revenue for ALMR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TECHBio-Techne CorporationLTM Sep 2026$420.61M -0.2%+4.3%34.2%
TWSTTwist Bioscience CorporationLTM Sep 2026$218.63M +17.8%+12.1%47.6%
TXG10x Genomics, Inc.LTM Sep 2026$173.93M -13.0%+18.2%28.1%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$100.69M -21.2%+11.3%62.9%
LABStandard BioTools Inc.LTM Mar 2026$44.6M -34.2%-11.1%51.7%
ALMRAlamar Biosciences, Inc.FY2025$32.51M ——43.8%
SEERSeer, Inc.LTM Mar 2026$7.78M -27.0%-0.2%51.7%
NAUTNautilus Biotechnology, Inc.LTM Mar 2026$6.32M -43.5%+23.7%—
QSIQuantum-Si incorporatedLTM Mar 2026$1.11M -31.7%—60.0%
Peer median (excluding ALMR) $72.64M-24.1%+11.3%51.7%

Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Alamar Biosciences, Inc.

NASDAQ:ALMR

Intrinsic Alpha fair value

Locked

Current Price

$30.51

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.